AGM
TWST icon

Alpine Global Management’s Twist Bioscience TWST Stock Holding History

Alpine Global Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-25,117
Closed -$527K – 425
2019
Q4 		$527K Buy
+25,117
New +$588K 0.11% 132

Other funds holding TWST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Alpine Global Management's TWST Position: Q1 2020 in Review

Alpine Global Management sold out of Twist Bioscience (TWST) in Q1 2020, closing a stake of 25,117 shares — an estimated $527K sold.

Alpine Global Management first reported a position in TWST in Q4 2019 and held it in 1 quarter. The position peaked at $527K in Q4 2019. 118 funds tracked by Wall St. Rank hold TWST as of Q1 2020.

  • Alpine Global Management reported no remaining Twist Bioscience position as of Q1 2020 after selling out during the quarter.
  • Alpine Global Management sold 25,117 Twist Bioscience shares in Q1 2020, an estimated $527K.
  • Alpine Global Management first reported a position in Twist Bioscience in Q4 2019 and held it in 1 quarter.
  • Alpine Global Management's Twist Bioscience position peaked at $527K in Q4 2019.
  • 118 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2020.

Based on Alpine Global Management's 13F filing for Q1 2020, filed 9 Apr 2020.